Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

400 Press Releases
DateTitleCompany
10 Oct 13 Teva to Report Third Quarter 2013 Financial Results on October 31, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Oct 13 Teva Accelerates Cost Reduction Program Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Oct 13 Teva Announces Launch of Generic Zemplar® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Sep 13 Teva In-Focus: A New Webinar Series for the Investment Community Focusing on Teva’s R&D Activities Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 Sep 13 Teva Announces Exclusive Launch of Generic ADENOSCAN® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Sep 13 Teva Announces Favorable Court Ruling in AZILECT® Patent Infringement Litigation Against Mylan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Sep 13 CORRECTING and REPLACING Teva Announces Exclusive Launch of Generic NIASPAN® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Sep 13 Teva Announces Exclusive Launch of Generic NIASPAN® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Aug 13 Teva Reports Top-Line Results from Final Phase III Study of Armodafinil (NUVIGIL®) in Patients with Major Depression Associated with Bipolar I Disorder Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Aug 13 Leading Proxy Advisory Firms Recommend Vote in Favor of All Proposals for Teva Pharmaceutical's Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
13 Aug 13 Teva to Present at the Canaccord Genuity 33rd Annual Growth Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
16 Jul 13 Teva to Report Second Quarter 2013 Financial Results on August 1, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 Jun 13 Teva Launches Generic Version of Viagra® (sildenafil) in Countries Across Europe Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Jun 13 Teva Strengthens Respiratory Franchise with Acquisition of MicroDose Therapeutx Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Jun 13 Teva to Present at the Goldman Sachs 34th Annual Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Jun 13 Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Generic Protonix® (Pantoprazole) Tablets Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 May 13 Teva Announces FDA Acceptance of sNDA for a Higher Concentration Dose of COPAXONE® Given Three Times a Week Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 May 13 Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Apr 13 Teva Establishes Global Specialty Medicines Group Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
29 Apr 13 Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Mar 13 Teva to Present at the 2013 Barclays Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Apr 13 Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Mar 13 Teva Calls 5.550% Senior Notes Due 2016 for Redemption Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Mar 13 Teva Files 2012 Annual Report on Form 20-F Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Apr 13 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Apr 13 Teva to Report First Quarter 2013 Financial Results on May 2, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Feb 13 Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Feb 13 Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Feb 13 Teva Announces FDA Approval of Generic Adderall XR® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Apr 13 Teva Presented New Data from Phase III Clinical Trial of Milprosa™ (Progesterone) Vaginal Ring at the 61st Annual Meeting of the Pacific Coast Reproductive Society Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.